COCO/DAND5 inhibits developmental and pathological ocular angiogenesis

COCO/DAND5 inhibits developmental and pathological ocular angiogenesis

Abstract Neovascularization contributes to multiple visual disorders including age‐related macular degeneration (AMD) and retinopathy of prematurity. Current therapies for treating ocular angiogenesis are centered on the inhibition of vascular endothelial growth factor (VEGF). While clinically effec...

Full description

Bibliographic Details
Main Authors: Natalija Popovic, Erika Hooker, Andrea Barabino, Anthony Flamier, Frédéric Provost, Manuel Buscarlet, Gilbert Bernier, Bruno Larrivée
Format: Article
Language:English
Published: Springer Nature 2021-02-01
Series:EMBO Molecular Medicine
Subjects:
angiogenesis
COCO
energy metabolism
ocular pathologies
Online Access:https://doi.org/10.15252/emmm.202012005

Internet

https://doi.org/10.15252/emmm.202012005

Similar Items